跳至主要内容
临床试验/NCT00631501
NCT00631501Unknown不适用

Doxycycline for Lateral Epicondylalgia - RCT

Kaunas University of Medicine1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2008年3月7日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
34
试验地点
1
主要终点
Pain (VAS)

研究概览

简要总结

Matrix metalloproteinases are involved in the pathogenesis of tendinopathy. Doxycycline, a widely available pharmaceutical agent mostly used for its antibiotic properties, also functions as an inhibitor of MMPs.

This study aims to investigate the effect of doxycycline treatment on lateral epicondylalgia (tennis elbow). During three weeks, patients receive doxycycline tablets 100 mg twice daily, or placebo. Main outcome variable is pain (VAS) at three weeks.

Serum and/or plasma levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases are measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-65
  • Pain at the lateral side of the elbow ≥8 weeks
  • Local tenderness on palpation of the lateral epicondyle
  • Pain on resisted extension of the wrist

排除标准

  • Rheumatic disorder
  • History of fibromyalgia or generalised pain
  • Elbow surgery (on the painful side)
  • Active infection
  • Glucocorticoid treatment during the duration of symtoms of epicondylalgia
  • NSAID use within 1 w before presentation and during the study
  • Pregnancy
  • Taking drug that might interact with doxycycline

研究组 & 干预措施

2

Placebo Comparator

干预措施: Placebo (Drug)

Doxycycline

Experimental

100 mg twice daily

干预措施: Doxycycline (Drug)

结局指标

主要结局

Pain (VAS)

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验